Literature DB >> 12236168

K channels as molecular targets for the treatment of erectile dysfunction.

George J Christ1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12236168

Source DB:  PubMed          Journal:  J Androl        ISSN: 0196-3635


× No keyword cloud information.
  8 in total

Review 1.  Molecular mechanisms of detrusor and corporal myocyte contraction: identifying targets for pharmacotherapy of bladder and erectile dysfunction.

Authors:  George J Christ; Steve Hodges
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

2.  Neuroregenerative strategies after radical prostatectomy.

Authors:  Robert C Dean; Tom F Lue
Journal:  Rev Urol       Date:  2005

Review 3.  The future is today: emerging drugs for the treatment of erectile dysfunction.

Authors:  Maarten Albersen; Alan W Shindel; Kuwong B Mwamukonda; Tom F Lue
Journal:  Expert Opin Emerg Drugs       Date:  2010-09       Impact factor: 4.191

Review 4.  Physiology and biochemistry of erections.

Authors:  George J Christ; Tom Lue
Journal:  Endocrine       Date:  2004 Mar-Apr       Impact factor: 3.925

5.  The Effect of Alcohol Administration on the Corpus Cavernosum.

Authors:  See Min Choi; Deok Ha Seo; Sin Woo Lee; Chunwoo Lee; Seong Uk Jeh; Sung Chul Kam; Jeong Seok Hwa; Ky Hyun Chung; Jae Seog Hyun
Journal:  World J Mens Health       Date:  2016-12-22       Impact factor: 5.400

6.  Neuronal Voltage Gated Potassium Channels May Modulate Nitric Oxide Synthesis in Corpus Cavernosum.

Authors:  Amira M Senbel; Heba M Abd Elmoneim; Fouad M Sharabi; Mahmoud M Mohy El-Din
Journal:  Front Pharmacol       Date:  2017-05-26       Impact factor: 5.810

Review 7.  Gene therapy treatments for erectile and bladder dysfunction.

Authors:  George J Christ
Journal:  Curr Urol Rep       Date:  2004-02       Impact factor: 2.862

8.  Role of different types of potassium channels in the relaxation of corpus cavernosum induced by resveratrol.

Authors:  Selvinaz Dalaklioglu; G Ozbey
Journal:  Pharmacogn Mag       Date:  2014-01       Impact factor: 1.085

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.